Policy Workshop: Life Sciences
Life Sciences: The Latest
  • EU Highlights
  • Viewpoints
And now for another smash hit…
CERN is getting ready to switch on its massive underground collider again. The Higgs boson, the standout discovery of the last few years, is in the bag, so what are physicists looking for now?
And the winners are … EIT picks Roche and Helmholtz groups to start new KICs
Innovation clusters in life sciences and raw materials set to start in 2015, following year-long bidding competition
Corporate R&D spending in Europe slows, Commission says
In 2013, the growth rate of private R&D investment in Europe fell to 2.9 per cent, due to falling corporate profits and a weak pharma and tech sector
Our research saves lives – if you let us
A new EU data protection law risks killing some types of medical research, researchers at the Karolinska Institutet say. Their prescription: A law that regulates Big Data, but allows for research
How to make regenerative medicine happen
Cell therapies hold the promise of more effective treatments for a range of diseases, but they face a long and expensive route to market. The key is to reduce risk and attract investors, says Keith Thompson, head of the UK Cell Therapy Catapult
Vital life sciences research is impeded by a lack of understanding of the role of patents
The uncertainty sparked by the US ruling that the BRCA1 and BRCA2 breast cancer genes are not patentable is holding back the development of diagnostics and therapies, says patent lawyer Adrian Tombling
Life Sciences Archive
Surprise departure of Karolinska Development chief executive
Company cites ‘serious disagreements’ with Lucidi over implementation of strategy
Imperial: First successful organ donation from newborn carried out in UK
Doctors at Imperial College Healthcare NHS Trust have reported the first successful organ donation from a newborn to be carried out...
Syncona LLP and UCL Business PLC Announce the Formation of Autolus Limited, a Cancer Immunotherapy Company
Syncona LLP (“Syncona”) and UCL Business PLC (“UCLB”), the wholly-owned technology transfer company of University College London (“UCL”), announce the creation...
King's College London signs licence agreement with UCB in immunology and type 1 diabetes
King’s College London announced that it has entered an exclusive licence agreement with UCB that grants the company the rights to...
Warwick: New “triggered-release” mechanism could improve drug delivery
More efficient medical treatments could be developed thanks to a new method for triggering the rearrangement of chemical particles.
Page 1 of 677> 1 2 3  ... 
Innovation in Progress - Science|Business Network
Surprise departure of Karolinska Development chief executive
Company cites ‘serious disagreements’ with Lucidi over implementation of strategy
Imperial: First successful organ donation from newborn carried out in UK
Doctors at Imperial College Healthcare NHS Trust have reported the first successful organ donation from a newborn to be carried out in the UK.
Syncona LLP and UCL Business PLC Announce the Formation of Autolus Limited, a Cancer Immunotherapy Company
Syncona LLP (“Syncona”) and UCL Business PLC (“UCLB”), the wholly-owned technology transfer company of University College London (“UCL”), announce the creation...
Horizon 2020 Special Coverage
The Food Innovation Summit (Partner event)
With a mix of keynote speeches, plenary sessions and workshops, the Food Innovation Summit is based on a tripartite approach and...
Radisson Blu Royal Hotel, Brussels - 03 February 2015
From open science to open innovation: How to get more jobs and growth from EU science investments
A Science|Business public conference
Brussels - 24 February 2015
Disease prevention: Meeting the challenge
A high-level roundtable as part of the Science|Business foresight series
Brussels - 24 March 2015
Unlocking the value of Personalised Healthcare in Europe
This new study shows ICT investments could cut healthcare costs for key ailments by more than 35%.
Bigger and Simpler: A short guide to the EU's €80 billion Horizon 2020 programme
A two-year political fight formally began in Brussels on 30 November with the publication of the European Commission's plan for Horizon 2020, its omnibus R&D programme. It promises less red tape, broader benefits, and more jobs and economic growth.
Biofuels: The Next Generation
Key ideas and recommendations to accelerate the deployment of sustainable biofuels have emerged at the second in a series of three high-level academic policy debates on the energy R&D challenge, The Energy Difference
Advertisement